Table 1.
Summary of the metabolites from essential PUFAs involved in the inflammatory processes in the skin
| Metabolite | Pathway | Receptors | Main Biological Effects | Cellular Origin in the Skin |
|---|---|---|---|---|
| PGE2 | COX | EP1, EP2, EP3, and EP4 | Vasodilatation, chemotaxis, cell proliferation, and modulation of immune response | Epidermal keratinocytes and dermal fibroblasts |
| PGD2 | COX | CRTH2, DP2 or GPR44 | Immunomodulation (platelet aggregation) | Epidermal keratinocytes, mast cells, and Langerhans cells |
| PGI2 | COX | IP | Vasodilatation and inhibition of platelet aggregation | Dermal fibroblasts |
| TXA2 | COX | TP | Vasoconstriction and platelet aggregation | Epidermal keratinocytes |
| LTB4 | 5-LOX | BLT1 and BLT2 | Chemotaxis | Infiltrating neutrophils and epidermal keratinocytes (lower levels) |
| 12-HETE | 12-LOX | 12-HETER | Chemotaxis, leucocyte migration, cell proliferation | Epidermal keratinocytes and dermal fibroblasts |
| 15-HETE | 15-LOX | PPAR-γ | Counteract 12-HETE and LTB4 effects, reduces polymorphonuclear leukocytes infiltration, and act as biochemical precursor of LXA4 | Epidermal keratinocytes, and dermal fibroblasts |